Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer
Conclusions
The use of CPT-11/NED as a NAC regimen shows favourable activity, with lower toxicity compared with NAC using TUAC or chemoradiotherapy, for the treatment of locally advanced cervical cancer.
Source: Journal of International Medical Research - Category: Research Authors: Abou-Taleb, H. A., Koshiyama, M., Matsumura, N., Baba, T., Yamaguchi, K., Hamanishi, J., Abiko, K., Yamanoi, K., Murakami, R., Horikawa, N., Taha, A. A., Kitamura, S., Konishi, I. Tags: Clinical Reports Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Cystitis | Hysterectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Thrombocytopenia | Toxicology